Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
(KOSN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: KOSN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on KOSN
Navigating the Micro-Cap Biotech Minefield
[View article]
no, no, gone with my former blog site, yes On May 16 02:32 PM drbob66 wrote: > Hmmm...does the author have any favorites? Or any...
More »
Comment by
Mike Havrilla
May 16 14:48 pm
|
Rating:
0
0
Navigating the Micro-Cap Biotech Minefield
[View article]
Hmmm...does the author have any favorites? Or any opinion at all about these companies? And...I don't see any table. Where did it go? Am...
More »
Comment by
drbob66
May 16 14:32 pm
|
Rating:
0
0
Even Fatter Yields for Pfizer; M&A Targets in the Sector
[View article]
Anybody out there follow a little biomed in Petaluma, CA named Oculus Innovative Sciences OCLS. From the DD I've done on the...
More »
Comment by
willytheg
Oct 19 00:10 am
|
Rating:
0
0
Even Fatter Yields for Pfizer; M&A Targets in the Sector
[View article]
Agree. Looks like PFE has now got new direction. At last the management is re-energized. 1. Pipeline is looking good; that they...
More »
Comment by
Shiv Kapoor
Oct 17 09:33 am
|
Rating:
0
0
Even Fatter Yields for Pfizer; M&A Targets in the Sector
[View article]
Pfizer will go spend money on acquisitions. The strategy change will require new pipelines. Watch for EPicept EPCT (drug just approved...
More »
Comment by
Vmatulis
Oct 17 07:35 am
|
Rating:
0
0
Cancer Stocks Plunge Following ASCO Meeting
[View article]
EXCELLENT JOB,
Comment by
User 155044
Sep 30 10:33 am
|
Rating:
0
0
Cancer Stocks on the Go: Winners and Losers
[View article]
I agree with paviov, However I would like to know about the new developments the phase II and III studies that are going well, where...
More »
Comment by
Olboy2
Aug 13 14:56 pm
|
Rating:
0
0
Kosan Acquired by Bristol-Myers for 233% Premium
[View article]
I've said it before... I'll say it again.... I can't edit this and I'm not the one adding the stock symbol information. I write on a...
More »
Comment by
Eben Tessari
Jul 21 08:21 am
|
Rating:
0
0
Kosan Acquired by Bristol-Myers for 233% Premium
[View article]
Can't this article be edited? It's about a month since "no name" commented on the mistake of putting in BMS for BMY and people are...
More »
Comment by
Leser
Jul 14 12:23 pm
|
Rating:
0
0
Kosan Acquired by Bristol-Myers for 233% Premium
[View article]
Eben Tessari - The stock symbol for this article is wrong: BMS is the symbol for The Bemis Co.; not a drug company.
Comment by
no name
Jun 17 15:10 pm
|
Rating:
0
0
Cancer Stocks Hammered Once Again
[View article]
Alan, What are your thoughts on Chemokine Therapeutics Corp (CHKT)? And Meridian Co LTD (MRDAF)?
Comment by
bsrichard
Mar 6 15:32 pm
|
Rating:
0
0
Cancer Stocks Hammered Once Again
[View article]
please ignore the comment above. it was posted in the wrong thread.
Comment by
bsrichard
Mar 6 11:48 am
|
Rating:
0
0
Cancer Stocks Hammered Once Again
[View article]
Maybe BofA should by this one too. Which bank took the highly rated debt at a discount from TMA?
Comment by
bsrichard
Mar 6 11:47 am
|
Rating:
0
0
Cancer Stocks Hammered Once Again
[View article]
I don't know the company, but it sure looks interesting. Technically, it would be nice to hold 1.75. The company is seemingly...
More »
Comment by
Alan Brochstein
Mar 5 19:06 pm
|
Rating:
0
0
Cancer Stocks Hammered Once Again
[View article]
Hi Alan, What is your current opinion on Clarient (CLRT)? Thanks very much, Don
Comment by
bsrichard
Mar 5 12:23 pm
|
Rating:
0
0
1
2
Next Page
Navigating the Micro-Cap Biotech Minefield [View article]
Navigating the Micro-Cap Biotech Minefield [View article]
Even Fatter Yields for Pfizer; M&A Targets in the Sector [View article]
Even Fatter Yields for Pfizer; M&A Targets in the Sector [View article]
Even Fatter Yields for Pfizer; M&A Targets in the Sector [View article]
Cancer Stocks Plunge Following ASCO Meeting [View article]
Cancer Stocks on the Go: Winners and Losers [View article]
Kosan Acquired by Bristol-Myers for 233% Premium [View article]
Kosan Acquired by Bristol-Myers for 233% Premium [View article]
Kosan Acquired by Bristol-Myers for 233% Premium [View article]
Cancer Stocks Hammered Once Again [View article]
Cancer Stocks Hammered Once Again [View article]
Cancer Stocks Hammered Once Again [View article]
Cancer Stocks Hammered Once Again [View article]
Cancer Stocks Hammered Once Again [View article]